Veracyte Announces Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Veracyte (VCYT) PT Lowered to $10 at Piper Jaffray Following Results
August 4, 2016 7:18 AM EDTPiper Jaffray analyst William Quirk lowered his price target on Veracyte, Inc (NASDAQ: VCYT) to $10.00 (from $12.00) but maitnained a Overweight on the stock following results.
Quirk commented, "Veracyte reported a 23% yoy revenue increase to $14.7M, ~in line with the Street. EPS of ($0.40)... More
Veracyte (VCYT) Misses Q2 EPS by 7c
August 3, 2016 4:06 PM EDTVeracyte (NASDAQ: VCYT) reported Q2 EPS of ($0.40), $0.07 worse than the analyst estimate of ($0.33). Revenue for the quarter came in at $14.68 million versus the consensus estimate of $14.81 million.
For earnings history and earnings-related data on Veracyte (VCYT) click here.
... More